Albumin binding half-life extension: difference between revisions
Diff·revision 9 → 10·23:37, 25 Jan 2025
Difference between revision 9 and revision 10 of Albumin binding half-life extension. 6 lines changed; the page grew by 110 bytes.
| Revision 9 — 13:03, 4 Jan 2025 ChainCustodyChad (talk) expand §Physical basis 4,401 bytes +45 | Revision 10 — 23:37, 25 Jan 2025 BUD_Bertram (talk) expand §Physical basis 4,511 bytes +110 | ||
|---|---|---|---|
| 38 | <ref name="lau2015">Lau J, Bloch P, Schäffer L, et al. "Discovery of the once-weekly glucagon-like peptide-1 analog semaglutide." ''Journal of Medicinal Chemistry'' 58(18):7370–7380 (2015). DOI:10.1021/acs.jmedchem.5b00726. PMID 26308095.</ref> | 38 | <ref name="lau2015">Lau J, Bloch P, Schäffer L, et al. "Discovery of the once-weekly glucagon-like peptide-1 analog semaglutide." ''Journal of Medicinal Chemistry'' 58(18):7370–7380 (2015). DOI:10.1021/acs.jmedchem.5b00726. PMID 26308095.</ref> |
| 39 | 39 | ||
| + | 40 | == See also == | |
| + | 41 | * [[Semaglutide]] | |
| + | 42 | * [[Liraglutide]] | |
| + | 43 | * [[GLP-1 receptor agonist]] | |
| + | 44 | * [[Dipeptidyl peptidase-4]] | |
| + | 45 | ||
| 40 | {{DEFAULTSORT:Albumin binding half-life extension}} | 46 | {{DEFAULTSORT:Albumin binding half-life extension}} |
| 41 | [[Category:Pharmacokinetics]] | 47 | [[Category:Pharmacokinetics]] |